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Intestinal-derived ILCs migrating in lymph increase IFNγ
production in response to Salmonella Typhimurium infection
Verena Kästele 1, Johannes Mayer1, Edward S. Lee2, Natalie Papazian3, John J. Cole1, Vuk Cerovic4, Gabrielle Belz5, Michio Tomura6,
Gerard Eberl7, Carl Goodyear1, Rose A. Maciewicz1, Daniel Wall1, Tom Cupedo3, David R. Withers8 and Simon Milling1
Innate lymphoid cells (ILCs) are enriched in mucosae and have been described as tissue-resident. Interestingly, ILCs are also present
within lymph nodes (LNs), in the interfollicular regions, the destination for lymph-migratory cells. We have previously shown that LN
ILCs are supplemented by peripheral tissue-derived ILCs. Using thoracic duct cannulations, we here enumerate the intestinal lymph
ILCs that traffic from the intestine to the mesenteric LNs (MLNs). We provide, for the first time, a detailed characterisation of these
lymph-migratory ILCs. We show that all ILC subsets migrate in lymph, and while global transcriptional analysis reveals a shared
signature with tissue-resident ILCs, lymph ILCs express migration-associated genes including S1PRs, SELL (CD62L) and CCR7.
Interestingly, we discovered that while Salmonella Typhimurium infections do not increase the numbers of migrating ILCs, infection
changes their composition and cytokine profile. Infection increases the proportions of RORyt+ T-bet+ ILCs, levels of IFNγ, and IFNγ/
GM-CSF co-expression. Infection-induced changes in migratory ILCs are reflected in colon-draining MLN ILCs, where RORyt+ T-bet+
ILCs accumulate and display corresponding increased cytokine expression. Thus, we reveal that ILCs respond rapidly to intestinal
infection and can migrate to the MLN where they produce cytokines.
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INTRODUCTION
Innate lymphoid cells (ILCs), are present throughout the body and
make important contributions to tissue homoeostasis and
immunity. ILCs comprise three subsets termed ILC1, ILC2 and
ILC3, distinguished by their transcription factor profile and effector
cytokines.1–3 ILCs are distinct from NK cells and are collectively
termed ‘helper’ ILCs due to a lack of cytotoxic function and
identified by their common expression of IL-7Rα.2,4,5 These helper
ILCs are enriched at barrier sites including the gastrointestinal
tract, where they are described as tissue-resident populations.6–8
However, in human blood, whilst progenitor populations are
found, ILCs comparable to ‘mature’ tissue ILCs have also been
described.1,2,9,10 Furthermore. trafficking of ILCs from the intestine
to the MLN has been demonstrated, showing that not all murine
ILCs remain anchored in tissues.11 Therefore, secondary lymphoid
tissues contain migratory ILC populations, potentially enabling
tissue-derived ILCs to influence lymph node immune responses.
Dysregulation of ILC functions contributes to pathology in
inflammatory diseases, particularly at barrier sites.12–14 While
lymphoid tissue inducer cells (LTi), an ILC3 population, are required
for lymphoid organogenesis, the contributions of ILCs to adaptive
immunity in secondary lymphoid tissues are less well understood.
Although there is clear evidence for ILC regulation of adaptive
immunity,15–17 questions remain about where these interactions
occur and the contributions of tissue-derived ILCs.
In the MLNs, ILC2 and ILC3 are located in the interfollicular area
of the LN, where lymph enters the node. Migratory cells such as
dendritic cells (DCs) pass through this area.11,18 Because of the
location of ILCs in MLN, combined with their migratory capacity,
we hypothesised that lymph-migratory ILCs might be equipped to
influence the initiation of adaptive immune responses. To test this,
we assessed migratory cells in lymph isolated by thoracic duct
cannulations of either intact mice, or mice that had undergone
mesenteric lymphadenectomy. Here we provide an extended
description of these intestinal migratory ILCs in health and after an
acute infection. Interestingly, migratory ILCs change their compo-
sition and transcriptomic profile after Salmonella Typhimurium
(STM) infection. In infected mice we find more migratory RORyt+
T-bet+ ILCs, with increased levels of IFNγ and some co-expression
of GM-CSF. Similar cytokine and transcription factor profile
changes are observed in the colon-draining LN. Thus, migratory
ILCs respond to their environment, travel to the LNs, and are
equipped to contribute to immune responses therein.
RESULTS
A population of ILCs continuously migrates in intestinal lymph
ILCs at barrier sites have been mainly described as tissue-resident
cells, including in the gastrointestinal tract.6 Interactions of ILCs
with other immune cells are important for regulating adaptive
immune responses.15,19,20 The importance of ILCs in LNs has
recently been highlighted by reports that they contribute to the
regulation of commensal-specific T cells and IgA production.15,16
We previously reported that some ILCs in the MLNs originate from
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the intestine11 but much remains unknown, including a detailed
description of numbers and phenotype of migratory ILCs in steady
state and during inflammation. To assess whether ILCs traffic to
LNs via lymphatic vessels we characterised migratory cells in
afferent lymph, collected by thoracic duct cannulations. Lymph
was collected from both intact and mesenteric lymphadenecto-
mised (MLNx) mice.21 Cannulation of intact mice allows the
collection of cells that have exited the MLNs via the efferent
lymphatics (MLN-derived cells) (Fig. 1a), whereas pseudo-afferent
lymph from MLNx mice contains cells that have exited the
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intestine (tissue-derived cells) (Fig. 1b). After cannulation, lymph is
collected from conscious freely moving animals for 18–24 h. We
analysed the cellular composition of intestine-derived lymph by
staining for CD4 and CD8 T cells (CD45+ CD3+ CD5+ CD4+ or
CD8+), B cells (CD45+ B220+), dendritic cells (DCs) (CD45+ MHCII+
CD11c+) and ILCs (CD45+, CD3−, CD5−, B220−, CD11c−, CD11b−,
IL-7Ra+, intracellular CD3−) (gating strategy Fig. S1A, B). The
majority of intestinal migratory cells are B cells (60%), CD4+ T cells,
(20%) and CD8+ T cells (20%). DCs comprise 1% of migratory
cells21 (Fig. S1C). In both intestine- and MLN-derived lymph we
identified a small but consistent ILC population. Both intestine-
and MLN-derived lymph contain comparable frequencies of
migratory ILCs; 0.01–0.03% of CD45+ cells. This represents
~200–2000 ILCs migrating per 24 h (Fig. 1c). To confirm that
these cells belong to the ILC family, we assessed their expression
of Id2, a key transcription factor for ILC lineage specificity.22 We
examined Id2-GFP expression in cells from intestine-derived
lymph and MLNs of Id2GFP/+ mice.23 Whereas B cells and T cells
lack Id2 expression, 70–95% of DCs and ILCs in both afferent
lymph and MLNs were Id2 positive. Frequencies of Id2+ ILCs in the
lymph are comparable to frequencies in the MLN (Fig. 1d).
Although 10–20% of lymph-migratory ILCs appear Id2 negative,
they express Thy1.2 (Fig. 1e), indicating that they likely belong to
the ILC family.24
We analysed the subset composition of migratory ILCs by
staining for T-bet, GATA3 and RORyt. In tissue-derived lymph,
ILC1s (T-bet+, 40%) and ILC2s (GATA3+, 28%) were the most
frequent among total migratory ILCs (Fig. 1f, g). Interestingly,
although all ILCs subsets were also found in MLN-derived lymph,
the majority of ILCs exiting the MLNs (65%) are T-bet positive
ILC1s (Fig. 1g). Given that the composition of ILCs entering and
leaving the MLN is different, some ILCs appear not to leave the
MLN after having migrated from the intestine. Figure 1h shows the
proportions of each ILC type in the different anatomical
compartments. Although the majority of ILCs in the MLNs are
ILC3s, as previously reported,11 few ILC3s appear to migrate in the
lymph. Conversely, ILC1s were found at the highest frequencies in
both intestine-derived and MLN-derived lymph. To confirm that
few ILC3s migrate from the intestine, intestine-derived lymph ILCs
were stained for CCR6, and were also collected from a Rorc(γt)+/GFP
mouse. Both CCR6 and RORγt-GFP signals were detected at low
frequencies in intestine-derived lymph ILCs (~5% of total lymph
ILCs) (Fig. 1i). Together, these data demonstrate that all intestinal
ILC types migrate in lymph, although at different frequencies, and
some of these ILCs are retained in the LN.
ILCs migrate to MLNs from both the small intestine and colon
To address migratory intestinal ILCs dynamics in more detail, we
assessed whether ILCs from both the colon and the small intestine
migrate to the MLNs. We exposed MLNs of photoconvertible
Kaede mice to violet light.25 Kaede mice ubiquitously express the
Kaede green protein, which switches to Kaede red when exposed
to violet light. Using low-intensity violet LED lights, MLNs were
photoconverted while other tissues were light-protected to allow
tissue-specific photoconversion. Because lymphatic vessels of the
small intestine and the colon drain to different nodes within the
chain of MLNs,26 we separately analysed colon draining (cMLN)
and small intestine-draining MLN (sMLN), either immediately or
24, 48, or 72 h after MLN photoconversion. Cells located in MLNs
at the time of photoconversion express both the Kaede green and
the Kaede red proteins, whereas incoming migratory cells only
express Kaede green. We can therefore distinguish recently
migrated ILCs as Kaede green cells that lack the Kaede red. All
MLN ILCs expressed photoconverted Kaede red protein when
analysed immediately after photoconversion and no Kaede green
single positive cells are detectable (Fig. 1j). The frequency of
Kaede green-only migratory ILCs increases gradually up to 13% of
total MLN ILCs by 72 h post photoconversion (Fig. 1j). In contrast,
the majority of T cells have been replaced by incoming circulatory
T cells after only 24 h (70% Kaede green of total T cells) (Fig. S1D).
We detected similar frequencies of new incoming ILCs in both the
sMLN and cMLNs, (Fig. 1j). In addition, lower frequencies of CCR6+
ILCs are found, both in the incoming Kaede green ILCs and in the
lymph, than in Kaede red MLN-resident ILCs (Fig. S1E). Thus,
migratory ILCs do not become CCR6+ after reaching the MLN. In
summary, these data indicate that ILCs in the cMLN and sMLN are
supplemented at similar proportions by migratory ILCs.
Increased migration of colonic RORyt+ T-bet+ ILCs during S.
Typhimurium infections
We next assessed how intestinal infection impacts ILC migration.
Therefore, we infected mice with STM, after pre-treatment with
streptomycin.27 We chose STM infection because it provides a
model of acute colonic inflammation, with reported contributions
of ILCs in the early phase of the immune response.28 Consistent
with the infection being localised primarily in the colon, we
Fig. 1 A population of ILCs continuously migrates in intestinal lymph. Schematic figures of the lymphatic system in the small intestine of (a)
intact and (b) mesenteric lymphadenectomised mice are shown. Lymph and migratory cells were isolated by thoracic duct cannulation of
intact (MLN-derived lymph) or mesenteric lymphadenectomised (tissue-derived lymph) C57BL/6 mice and collected for 18–24 h. c ILCs in
tissue-derived and MLN-derived lymph were identified as live, single, CD45+ IL-7Rα+ lineage− (CD11b− CD11c− B220− CD3− CD5−
intracellular CD3−) cells. The percentage and total cell numbers of ILCs per cannulation were assessed by flow cytometry of at least three
independent experiments (n= 9–19). d Migratory ILCs were analyzed for Id2 expression by cannulating MLNxed Id2GFP/+ reporter mice.
Additionally, cells were isolated from mesenteric lymph nodes (MLNs) of age matched Id2GFP/+ reporter mice. A representative FACS plot for
Id2 expression in lymph ILCs (CD45+ IL-7Ra+ lineage− cells) and percentages of Id2 expression in MLNs and lymph ILCs, B cells (live, single,
CD45+ B220+ cells), T cells (live, single, CD45+ CD3+ CD5+ cells) and migratory DCs (live, single, CD45+ MHCIIhigh CD11c+ CD64− cells) are
shown. Data from two independent experiments for MLN and three independent experiments for lymph samples are shown. Each dot
represents an individual animal (n= 4–6). e FACS plot of Thy1.2 expression on migratory ILCs isolated from afferent lymph of Id2GFP/+ mice is
shown. f Plot shows tissue-derived cells isolated by thoracic duct cannulations of C57BL/6 mice that had undergone mesenteric
lymphadenectomy and ILC subsets were identified by staining for the transcription factors T-bet, GATA3 and RORγt. g MLN-derived cells and
tissue-derived cells were isolated by thoracic duct cannulation and the composition of ILCs assessed. Data are representative for at least three
independent experiments (n= 7–8). Each dot represents an individual animal. h Proportions of each type of ILCs in each tissue compartment
are represented by donut plots. Each donut represents data from at least two independent experiments (n= 6–8). i Percentages of CCR6
expressing ILCs in tissue-derived lymph of C57BL/6 mice are displayed. Data from three independent experiments are shown (n= 6). FACS
plot of RORyt expression in tissue-derived ILCs in a Rorc(γt)+/GFP reporter mouse that previously underwent mesenteric lymphadenectomy is
shown. j At laparotomy, MLNs of Kaede mice were exposed to low-intensity violet light. Small intestinal (sMLN) or colonic (cMLN) draining
lymph nodes were removed either immediately or after 24, 48 or 72 h. Representative FACS plots of photoconverted Kaede red ILCs (live,
single, CD45+ IL-7Rα+ lineage− Kaede green+ Kaede red+) and non-converted Kaede green ILCs (live, single, CD45+ IL-7Rα+ lineage− Kaede
green+ Kaede red−) in sMLNs at 0 and 72 h after laparotomy are shown. Graph displays the expression of non-converted Kaede green ILCs in
the sMLNs (dark colour) or cMLNs (light colour). Each dot represents an individual animal with sMLNs and cMLNs harvested from the same
animal (n= 5–8) in two independent experiments.
Intestinal-derived ILCs migrating in lymph increase IFNγ production in. . .
V Kästele et al.
3
Mucosal Immunology _#####################_
detected increased total cell numbers in the colonic lamina
propria and the cMLN, but not the small intestine or sMLN
(Fig. S1F). Because ILCs migrate from the colon to the cMLN, we
assessed whether infection increased the numbers of migratory
ILC in intestine-derived lymph. Thus, MLNx mice were infected
with STM and intestinal lymph was isolated 48 h post infection.
Control mice received streptomycin antibiotics (ABX) without
infection. Staining of lymph revealed that STM infection does not
alter the frequency or number of migratory ILCs in lymph (Fig. 2a).
However, intestine-draining lymph of STM-infected mice showed
an increased proportion of RORyt+ T-bet+ ILCs (labelled as T-bet+
ILC3s in figures), which are almost absent from lymph of control
mice (Figs. 1h and 2b). The changes in ILC frequencies that occur
in lymph after infection are summarised in Fig. 2c. Corresponding
to the changes in intestinal lymph, we detected an accumulation
of RORyt+ T-bet+ ILCs in the cMLN (Fig. 2d, e). The increased
proportion of RORyt+ T-bet+ ILCs in the lymph and MLN after STM
infection reflects changes in the colonic lamina propria, where this
population was decreased after STM infection (Fig. 2f). We
detected no differences in total ILC cell numbers or frequencies
of RORyt+ T-bet+ ILCs in the SI LP or sMLN (Fig. S1G, H). Thus,
following STM infection, changes in the composition of ILC
subsets were restricted to the colon and cMLNs, and correspond-
ing changes were observed in the migratory ILC population.
The transcriptomic profile of ILCs in lymph closely matches with
tissue-resident ILCs
To better characterise migratory ILCs we assessed their transcrip-
tomic profile, by global gene expression analysis, using total ILCs
from the lamina propria and total migratory ILCs from intestine-
derived lymph. Lymph samples were obtained both from animals
in the steady state and after STM infection. The ILCs were
compared with CD4+ T cells from lymph and lamina propria,
collected from the same steady state mice (sort purity shown in
Fig. S2A, B). Principal component analysis and unsupervised
clustering of the RNA sequencing data revealed that migratory
ILCs cluster tightly with tissue-resident ILCs in steady state and are
distinct from T cells (Fig. 3a, b). In the unsupervised heatmap of
genes that are differentially expressed in any combination (Fig. 3b),
clusters of genes associated with particular cells and conditions
can be seen. Cluster I is T-cell-specific. Cluster II contains genes
that are expressed at higher levels in the lymph. Cluster III is
Fig. 2 Increased migrating colonic RORyt+ T-bet+ ILCs after S. Typhimurium infection. C57BL/6 mice that previously underwent mesenteric
lymphadenectomy received streptomycin (ABX) or received streptomycin and were infected orally after 24 h with S. Typhimurium (STM).
Migratory cells were collected by thoracic duct cannulations 48 h post infection and cells collected for 18–24 h. Migratory cells were stained
with antibodies for phenotypic analysis by flow cytometry. a Graphs show the percentages and total cell numbers of migratory ILCs per
cannulation in lymph of Salmonella (STM) infected and control (ABX) mice. Each dot represents an individual animal (n= 7) from at least three
independent experiments. b ILC subsets were analysed by assessing the expression of the transcription factors T-bet, GATA3 and RORγt.
Representative FACS plots of T-bet and RORγt expression in migratory ILCs of STM and control mice are displayed. Graph shows the
percentages of ILC subsets in control an STM-infected mice. Each dot represents an individual animal (n= 7–9) from at least three
independent experiments. c Donut plots display the proportions of ILCs from control or STM-infected mice, Data from at least three
independent experiments are shown (n= 7–9). d Intact C57BL/6 mice received streptomycin (ABX) or received streptomycin and were
infected after 24 h with STM. Cells from colonic LP (C LP) and cMLNs were isolated 3 days post STM infection. ILC subsets were identified by
the expression of the transcription T-bet, GATA3 and RORγt. d Representative FACS plots of T-bet and RORγt stained ILCs in cMLNs of STM
infected and control mice are shown. Graph in (e) shows the composition of ILCs in the cMLN. f Shows ILC populations in the C LP of STM-
infected and control (ABX) mice. Each dot represents an individual animal (n= 8) from at least three independent experiments.
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upregulated in T cells and ILCs in the LP. Cluster IV is upregulated
in all ILCs, compared to T cells. Similar expression levels of Id2,
Zbtb16 and Gata3, all key transcription factors for ILC develop-
ment,1 were detected in both migratory and tissue-resident ILCs
(Fig. 3c). Consistent with the protein data in Fig. 1, we detected
low expression levels of Rorc in migratory ILCs compared to tissue-
resident ILCs whereas there was no difference in the expression
levels of T-bet (Fig. 3c). To investigate whether the migratory ILC
population was distinct from T cells, the most likely contaminant,
we examined expression levels of genes characteristic of intestinal
ILCs. As expected, lymph ILCs show higher expression levels of
Rxrg, Cxcr6, Gata3, Id2, Ahr, Rora, Espas1,29 and express low levels
of T cell associated transcripts Cd3e Cd3g, and Cd4 (Fig. 3d).
Migratory ILCs express genes involved in active migration
To assess whether the migratory ILCs in lymph actively migrate from
the intestine to the MLNs, we compared tissue-derived lymph cells
with their tissue-resident counterparts. We aimed to identify a
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migratory signature shared by T cells and ILCs. For this analysis, we
compared the global transcriptomic profile of ILCs and T cells with
similar profiles generated from CD103+ DCs and CD103+ CD11b+
intestinal lymph DCs (Fig. S2C). The DCs are used as a positive control
as their active migratory behaviour is well described.21,26,30 Interest-
ingly, all cell types share 32 genes that are significantly altered in the
migratory population compared to their intestinal tissue-resident
counterparts (Fig. 3e and DCs in Fig. S2C). All these genes have similar
patterns of expression in T cells and ILCs. We observed several genes
known to be associated with regulation of cell migration or motility
such as Rasgrp2,31 Satb1,32 S1pr1, S1pr433–35 and Sell (CD62L)36 to be
commonly upregulated in ILCs, T cells. and in DCs isolated from
lymph (Fig. 3e and DCs in S2D). Additionally, comparison of migratory
lymph ILCs with ILCs from the lamina propria, also revealed CCR7 and
CCR10 to be highly expressed in lymph ILCs, whereas lymph ILCs
display low expression of Cd69, Cxcr6, Ccrl2 and Ccr8 (Fig. 3f). We
validated transcriptome results with protein staining; we detected
CD62L-positive ILCs in intestine-derived steady state lymph (Fig. 3g).
We also detected positive protein staining for Ly6d and Ki-67 that
correlated with high levels of gene expression on intestine-derived
lymph ILCs (Fig. S2E, F). Furthermore, by photoconverting the MLNs of
Kaede mice, we detected that recently migrated ILCs lack CD69
(Kaede green cells), whereas up to 20% of tissue-resident ILCs (Kaede
red) are CD69 positive (Fig. 3h). Comparisons between the
transcriptomes of steady state lymph and tissue-resident ILCs provide
clues to the functions of these migratory ILCs. For instance, migratory
ILCs express higher levels of Pdcd1, Tigit and Cd1d1 (Fig. 3i) and of the
genes encoding cytokine receptors IL-12R and IL-17R (Fig. 3j). Thus,
migratory ILCs may be poised to respond to T-cell cytokines and
influence T-cell responses in the draining lymph node.
After infection, migratory ILCs express interferon response genes
To understand how migratory ILCs change during immune
responses, we compared migratory ILCs from STM-infected mice
to steady state migratory ILCs. 135 genes were significantly
upregulated and 77 genes downregulated in STM-infected lymph
ILCs (Fig. 4a). The complete list of all differentially expressed genes
is shown in Fig. S3A. Pathway analysis identified that migratory ILC
genes altered during STM infection are commonly associated with
interferon signalling (Fig. 4b). After STM infection migratory ILCs
express significantly higher levels of Ccl3, Gbp2, Gbp6, Irf1, Irf4, Irf7,
Pml and Stat1 (Fig. 4c), all of which are regulated in response to
interferon gamma. Thus, intestinal migratory ILCs appear able to
respond directly to cytokines. Because RORyt+ T-bet+ ILCs
increased in the lymph of STM-infected mice (Fig. 2b), we
assessed expression of ILC1- and ILC3-associated cytokine genes.
This revealed increased transcript levels of IL-22 in lymph ILCs
after STM infection (Fig. 4d). Furthermore, expression of
chemokine genes Ccl3, Cxcl2 and Cxcl10 also significantly
increased in migratory ILCs after STM infection (Fig. 4c, e). Thus,
after infection, ILCs show a diverse transcriptomic profile,
characterised by a strong response to interferon signalling.
Consequently, intestinal ILCs may release chemokines to recruit
immune cells, and also produce cytokines to shape adaptive
immune responses.
After STM infection migratory ILCs are activated, and display
increased IFNγ production
The changes in gene expression after STM infection indicate
activation of migratory ILCs. We therefore looked for correspond-
ing changes in protein expression indicative of ILC activation. As
transcripts encoding IL-22 were increased in lymph ILCs during
infection, we assessed the cytokine profile of migratory ILCs.
Although there was no difference in the percentages of ILCs
expressing IL-17A, IFNγ, GM-CSF or IL-22 between ILCs from steady
state and STM-infected mice, we identified increased expression of
IFNγ (assessed by analysing the MFI) after STM infection. During
STM infection we also observed an increased proportion of IFNγ/
GM-CSF co-expressing lymph-migratory ILCs (Fig. 5a–c). We
observed corresponding changes in MLN ILCs after STM infection.
The cMLN of STM-infected mice contained a lower frequency of IL-
17A producing ILCs, and increased proportions of IL-22 expressing
ILCs. We also detected an increased frequency of IFNγ-producing
ILCs in both the sMLN and the cMLN (Fig. 5d, e). Unlike in the
migratory ILCs, we do not detect an increase in the MFI for IFNγ in
MLNs after STM infection unless we pre-gate on IFNγ+ ILCs (Fig. 5f
and S3B, C). Interestingly, corresponding to the changed cytokine
profile detected in lymph, a population of IFNγ GM-CSF double-
producing ILCs is found in the cMLN of infected mice (Fig. 5f).
These data indicate that ILCs migrating from an inflamed
environment, such as in the colonic LP after STM infection, show
an activated phenotype and produce cytokines in the draining
LNs. Thus, a population of intestinal ILCs can respond to local
infection, migrate to the draining lymph node, and help to
establish the cytokine environment needed to successfully induce
adaptive immunity.
DISCUSSION
Intestinal ILCs play important roles in regulating tissue homoeostasis
and defence against pathogens. Their dynamics in lymph nodes are
less well understood. Here we show that all subsets of helper-like
ILCs migrate in intestinal lymph. Migratory intestinal ILCs derive from
both the colon and the small intestine and express molecules
required for migration (CCR7, CD62L, S1P1Rs). After STM infection
populations of lymph-migratory ILCs display increased expression of
Fig. 3 ILCs in lymph have a migratory gene expression signature. Cells from the lamina propria (LP) or lymph were isolated from C57BL/6
mice that previously underwent complete mesenteric lymphadenectomy. Lymph was isolated by thoracic duct cannulations and migratory
cells were collected for 18–24 h. a Principal component analysis of gene expression data for ILCs and T cells isolated from the LP and lymph in
steady state or after STM infection. The first two components are shown with replicates represented by dots. The total variation by each
component is shown. b Heatmap shows the significantly different genes (fold change >2 and adjusted p value < 0.01) between T cells and ILCs
isolated from the lamina propria and lymph in steady state and after STM infection. Genes (y-axis) and samples (x-axis) have been clustered
using spearman distances and UPGMA agglomeration. c Transcription levels of selected genes in ILCs isolated from lymph compared to the
lamina propria in steady state are displayed as FPKMs. d Plot shows the clustered expression levels of selected genes in ILCs compared to
T cells isolated from lymph in steady state. e Genes altered in all migratory cells (CD103+ DCs, CD103+ CD11b+ DCs, T cells and ILCs) isolated
from lymph compared to the lamina propria, in steady state (fold change >2 and adjusted p value < 0.01) were identified and expression levels
of genes for ILCs and T cells shown in graph. f Transcription levels of migration-associated genes in ILCs isolated from lymph compared to the
lamina propria in steady state are displayed as FPKMs. g Cells from lymph were isolated by thoracic duct cannulation of C57BL/6 mice that
previously underwent mesenteric lymphadenectomy. A representative FACS plot of CD62L and T-bet staining on ILCs in lymph is displayed.
FACS Plot is representative for two independent experiments (n= 2). h At laparotomy, MLNs of Kaede mice were exposed to low-intensity
violet light. Small intestinal (sMLN) or colonic (cMLN) draining lymph nodes were removed either immediately or after 24, 48 or 72 h. Isolated
cells were stained with antibodies for the analysis by flow cytometry and graphs display the percentages of CD69 expression on ILCs. Each dot
represents an individual animal with cMLN and sMLNs isolated from the same mouse (n= 3–5) of one experiment. i–j Transcription levels of
selected significantly altered genes in ILCs isolated from lymph compared to the lamina propria in steady state are displayed as FPKMs.
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RORyt+ and display elevated levels of IFNγ. These changes are
reflected in ILCs in colon-draining MLN, indicating that tissue-
derived ILCs contribute to shaping the LN environment.
As reported,6 we also find that most intestinal ILCs are tissue-
resident; only a small fraction migrate into the lymph. Previously it
has not been possible to detect ILC migration from tissue to LNs
unless the ILCs return to the circulation. Thus, ILC movements in
and out of MLNs have not previously been described. Interest-
ingly, while the majority of ILCs in the MLNs are ILC3s, these form
only a small fraction of lymph-migratory ILCs in the steady state
(Fig. 1h). ILC3s in MLNs are long-lived cells37 and our data indicate
that MLN ILC3 may be replenished by tissue-derived ILCs relatively
slowly compared to ILC1 and ILC2. Due to small numbers of ILCs in
the MLNs, migration of a small fraction of intestinal ILCs still
replenishes 10% of MLN ILCs within 48 h (Fig. 1k).
In MLN-derived lymph, the majority of ILCs are ILC1s (Fig. 1h),
consistent with previous observations.6,38 Thus, a population of
ILC1s, like NK cells,39 circulates between LNs.
Analysis of the transcriptomes of migratory ILCs and tissue ILCs,
revealed a migratory signature shared with both DCs and CD4+
T cells (Fig. 3e). Our intestinal migratory ILCs, express S1P
receptors, CCR7, CD62L and lack CD69. An ILC2 population that
traffics from the intestine to the lung during helminth infections
displays similar properties, expressing S1PRs but not CD69.34 Thus,
all ILCs may depend on similar receptors for their migration.
Migration requires a co-ordinated and complex set of changes in
gene expression, and only a small proportion of ILCs undergo
these changes, even after STM infection; these will be an
important focus of future work.
After infection with STM migratory ILCs appear to respond to
interferons (Fig. 4), and a population of migratory RORyt+ T-bet+
ILCs increases (Fig. 2). Infection induces increased ILC production
of IFNγ, and some begin to co-express GM-CSF (Fig. 5). This co-
expression of IFNγ and GM-CSF in migratory ILCs correlates with
the increase in the proportion of RORyt+ T-bet+ ILCs. This RORyt+
T-bet+ ILC population is an important early source of IFNγ in the
lamina propria during STM infection,28 and it would be interesting
to examine whether this may also contribute to the GM-CSF
produced in the intestine after STM infection. Here we now show
that RORyt+ T-bet+ ILCs may also be crucial in the draining LNs
early during the immune response. Indeed, consistent with our
lymph data, we detect a parallel accumulation of RORyt+ T-bet+
ILCs, and changes in the cytokine profile of ILCs in the MLNs
during STM infection. It is possible, and perhaps likely, that
migratory ILC1s and/or MLN-tissue-resident ILCs might also
contribute to the cytokine profile observed in cMLN ILCs in
response to STM infections (Figs. 3 and 5).
During Th1 priming, IFNγ in the lymph node drives the
differentiation of Th1 cells. NK cells are an early source of this
IFNγ.40 We now show that migratory ILCs are also an early source
of IFNγ in the LN. Similarly, the GM-CSF released by ILCs locally in
the interfollicular area might further support the anti-STM
response by enhancing T cell priming by DCs,41 and by recruiting
other immune cells, including neutrophils, into the MLN.42,43 The
specific location of ILCs in the LN interfollicular area, close to DCs,
T cells and B cells,11 makes them credible as influencers of
adaptive immune responses. Furthermore, migratory ILCs express
increased levels of Cxcl10 after STM infection so may actively
contribute to intranodal positioning of CXCR3-expressing T cells44
and recruitment of NK cells40 into the MLN to enhance Th1
responses. Thus, migratory ILCs may contribute to T-cell differ-
entiation by augmenting critical cytokine levels early during the
response in the MLN, and by contributing to recruitment of both
cytokine-producing and responder cells. However, many ques-
tions still remain, including: what signals drive ILC to exit the
tissue; how is migration regulated during inflammation; and in the
absence of migratory ILCs, are adaptive immune responses less
efficiently induced, or delayed?
Our data provide a detailed characterisation of migratory
intestinal ILCs. We show that migratory ILCs supplement ILCs in
Fig. 4 Migratory ILCs express Interferon response genes and change their transcriptional profile. a Heatmap is showing the significantly
different genes (fold change >2 and adjusted p value < 0.01) between migratory ILCs isolated from lymph in steady state and STM-infected
mice. Genes (y-axis) and samples (x-axis) have been clustered using spearman distances and UPGMA agglomeration. b The top altered
pathways in lymph ILCs after Salmonella infection compared to steady state migratory ILCs are shown. c Significantly altered genes in STM-
infected ILCs that mapped to the cellular response to interferon gamma pathway are displayed as FPKMs. d Selected cytokines and
chemokines are displayed as FPKMs. e Selected genes in migratory ILCs in lymph of STM-infected mice compared to steady state are shown.
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lymph nodes, and that infection activates migratory ILCs. These
data indicate the potential for crosstalk between migratory ILCs
and other immune cells in the LN, which may contribute to the
early events that shape adaptive immune responses.
MATERIAL AND METHODS
Mice
C57BL/6 mice were purchased from Envigo Laboratories at
5–8 weeks of age and maintained in individually ventilated cages
Fig. 5 Migratory ILCs display an activated phenotype and display increased IFNγ production during STM infection. a C57BL/6 mice that
previously underwent mesenteric lymphadenectomy received streptomycin (ABX) and were infected after 24 h with STM. Migratory cells were
collected by thoracic duct cannulations on day 2 post infection. ILCs were analysed for the expression of IL-17A, IFNγ, IL-22 and GM-CSF.
Cytokine expression is compared to migratory ILCs in the steady state. Representative FACS plots and (b) a graph displaying the percentages
of cytokine expressing ILCs are shown. c Mean fluorescent intensity (MFI) of IFNγ and percentages of IFNγ GM-CSF co-expressing ILCs in
pseudo-afferent lymph of ILCs in steady state and Salmonella infected mice is displayed. Each dot represents an individual animal and data are
from at least two independent experiments (n= 5–10). d C57BL/6 mice received Streptomycin (ABX) and were infected after 24 h with
S. Typhimurium (STM). Control mice received Streptomycin only. Cells from the sMLN and cMLN were isolated 72 h post STM infection. ILCs in
the MLNs were assessed for expression of the cytokines IL-17A, IFNγ, IL-22 and GM-CSF. Representative FACS plots and (e) graphs display the
percentages of cytokine expressing ILCs in the sMLN and cMLN. f Mean fluorescence intensity (MFI) of IFNγ and percentages of IFNγ GM-CSF
co-expressing ILCs in MLN ILCs in ABX control and STM-infected mice is displayed. Data from two independent experiments are shown with
each dot representing an individual animal (n= 8).
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(IVC) at the Central Research Facility, Glasgow, UK. Id2+/GFP and
Rorc(γt)+/GFPmice were bred at the Veterinary Research Facility,
Glasgow, UK. Id2+/GFP mice were originally generated by Gabrielle
Belz (Walter and Eliza Hall Institute of Medical Research,
Australia)23 and Rorc(γt)+/GFP mice were generated by Gerard
Eberl (Institut Pasteur, France).45 Kaede mice (originally from Kenji
Kabashima)46 were bred at the Central Research Facility, Glasgow,
UK. All mice were bred and housed under specific pathogen free
conditions. All procedures were approved by the local ethical
committee and carried out under licenses issued by the UK Home
Office.
Surgical procedures
Kaede photoconversion. As previously reported,26 for the photo-
conversion of the Kaede green protein in the MLN, the lymph
nodes of Kaede transgenic mice were exposed to low-intensity
violet light (395 nm UV LED) for 6 min after laparotomy. The MLNs
were exposed to the violet light whilst protecting the surrounding
tissue from light using aluminium foil.
Mesenteric lymphadenectomy and thoracic duct cannulations.
Mesenteric lymphadenectomy and thoracic duct cannulations
were performed according to published protocols.47 Mesenteric
lymphadenectomy was performed on 5–9-week old male mice.
Thereby, the complete MLN chain was removed by blunt
dissection after laparotomy. Mice were allowed to recover for at
least 6 weeks in IVCs before the thoracic duct was cannulated.
Lymph was collected on ice for 18–24 h in PBS with 20 U/ml of
heparin (Wockhardt).
Cell isolations from tissues. For the isolation of cells from the
small intestinal and colonic lamina propria, the tissues were cut
longitudinally and into sections following the removal of fat.
Peyer’s Patches (PPs) were removed from SI samples. The tissues
were incubated for two rounds in HBSS with 2 mM EDTA at 37 °C,
for 20 min for the SI or 15min for the colon, in a shaking
incubator. The SI was digested in complete RPMI supplemented
with 1 mg/ml Collagenase VIII (Sigma) at 37 °C for ~15 min. The
colon was digested in complete RPMI containing 0.85 mg/ml
Collagenase VIII (Sigma), 1.25 mg/ml Collagenase D (Roche,
Switzerland), 1 mg/ml Dispase (Gibco) and 30 μg/ml DNAse
(Roche) at 37 °C for ~40min. After the digest, cells were passed
through a 100 and 40 μm cell strainers.
LNs were cut into smaller pieces and digested for 20 min at 37 °
C in RPMI supplemented with 0.075 mg/ml DNAseI (Roche) and
0.75mg/ml Collagenase-Dispase (Roche). After the digest, cells
were passed through a 40 μm cell strainer.
Lymph cells were passed through a 40 μm cell strainer.
S. Typhimurium infections. Mice received 20mg streptomycin
(Sigma) in 100 μl PBS via oral gavage 24 h before infection with
Salmonella enterica serovar Typhimurium (S. Typhimurium) SL1344.
S. Typhimurium was grown in luria broth (LB) at 37 °C for 5 h at
180 rpm. After incubation, the cultures were diluted 1:2 in LB and
further kept in a static incubator overnight. The following day,
bacterial cell density was adjusted to an OD600 of 0.75. Intact or
lymphadenctomised mice received 5–8 × 107 colony forming units
bacteria in 100 μl PBS via oral gavage.
Cell stimulation for cytokine analysis. For the analysis of cytokine
expression, cells were stimulated with the eBioscience cell
stimulation cocktail including protein transport inhibitors for 4 h
at 37 °C according to the manufacturer’s instructions (Thermofisher
scientific).
FACS antibody staining. Antibody staining for extracellular
molecules was performed at 4 °C for 30min. Intracellular staining
was performed at room temperature for 1 h using the FoxP3
fixation and permeabilisation kit (Thermofisher scientific) accord-
ing to the manufacturer’s instructions. The following antibodies
were purchased from Biolegend: B220 (RA3-6B2), CCR6 (29-2L17),
CD11b (M1/70), CD11c (N418), CD45 (30-F11), I-Ab (M5/114.15.2),
IL-7Rα (A7R34), CD44 (IM7), CD64 (X54-5/7.1), CD4 (GK1.5), CD8α
(53-6.7), CD19 (6D5), CD103 (2E7), IL-17A (TC11-18H10.1), CD5 (53-
7.3), CD3 (17A2), CD44 (IM7), CD25 (PC61), CD62L (MEL-14), CD69
(H1.2F3). Ly6D (49-H4), GM-CSF (MP1-22E9), IL-22 (Poly5164), Thy-
1.2 (53-2.1). Other antibodies were purchased from BD Bios-
ciences: IFNγ (XMG1.2), CD11c (HL3) or from Thermofisher
scientific: CD3ε (145-2C11), GATA3 (TWAJ), RORγt (AFKJS-9),
T-bet (eBio4B10), Ki-67 (SolA15).
The eFluor 780 viability dye (Thermofisher scientific) was
added to identify live cells. Samples used for cell sorting were
incubated with the dead live dye 7AAD (Biolegend). Flow
cytometry analyses were performed on LSR II, LSR Fortessa
analyser, FACSAria IIu or FACSAria III cell sorter (all BD
Biosciences) using the FACSDiva6.2 software (BD Biosciences),
or sorted by fluorescence-activated cell sorting using the
FACSAria IIu or FACSAria III cell sorter. Data were subsequently
analysed with the FlowJo software (Tree Star).
RNA sequencing. Cells were isolated from C57BL/6 mice that
previously underwent complete mesenteric lymphadenectomy.
ILCs were identified as live, single, CD45+ IL-7Rα+ lineage− (CD3,
CD5, CD11b, CD11c, B220) cells and T cells as live, single, CD45+
CD11b− CD11c− B220− CD3+ CD5+ CD4+ CD44high CD25- cells.
Cells for RNA seq were purified by flow cytometric sorting, collected
into 350 μl RLT plus buffer (Qiagen) and stored at −80 °C until
further processing. Samples were sorted in quadruplicates and
isolated cell types included migratory ILCs (n= 15) and T cells (n=
8) from afferent lymph of thoracic duct cannulated mice in steady
state, ILCs (n= 4) and T cells (n= 4) from the colonic and small
intestinal lamina propria at similar proportions, and migratory ILCs
(n= 25) from afferent lymph of Salmonella infected mice that
underwent thoracic duct cannulation. RNA was isolated according
to the manufacturer’s protocol (RNAeasy plus micro kit, Qiagen).
CD11b+ CD103− and CD11b+ CD103+ DCs (live, single,
CD45+, CD64− MHCIIhigh CD11c+) were isolated from the small
intestinal lamina propria of C57BL/6 mice after removal of PPs.
The migratory DC counterparts were isolated by thoracic duct
cannulations of mice that previously underwent complete
mesenteric lymphadenectomy. RNA was isolated according to
the manufacturer’s protocol (RNAeasy kit, Qiagen).
The ILC and T-cell sequencing libraries were prepared
according to published protocols,48 using a TAKARA SMART-
seq v4 ultra low input library preparation kit with 15 cycles of
amplification, and were sequenced to a mean depth of 5.1
million read pairs per sample using an Illumina HiSeq 2500.
The DC sequencing libraries were prepared using a TAKARA
SMART-seq v4 ultra low input library preparation kit, and were
sequenced to a mean depth of 37.5 million read pairs per
sample using an Illumina HiSeq 4000. The read length for both
libraries was 75 bp. A high read quality (mean score above 28) in
all samples was confirmed using FastQC. Reads were aligned to
the mouse genome (GRCm38) using Star (v2.6.0c)49 with the
parameters –quantMode GeneCounts, –outFilterMultimapNmax
1 and –outFilterMatchNmin 35. The Star index was generated
with the parameters –sjdbGTFfile (transcriptome version 93)
and –sjdbOverhang 74. The mean alignment rate was above
85% per sample. Read counting was performed by star using
unstranded counting for both datasets. For both datasets
normalised counts and differential expression values were
generated using DESeq250 under default settings. Genes with
an adjusted p value of less than 0.01 and an absolute fold
change of greater than 2 were considered significant.
The RNA-seq data, available at the NCBI GEO database
(GSE160156), was explored using Searchlight 2 (v2.0.0a)51 and
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R (version 3.4.4). Specifically, enrichment of gene ontologies
was generated using a standard hypergeometric test with
Benjamini–Hochberg multisample correction, and the gene-set
database Gene Ontologies Molecular Function (GO_MF) as
downloaded from MsigDB collections.52 Principal Component
analysis was performed on Z-score transformed expression data,
using R. Heatmap clustering was performed using the R package
fastcluster using spearman distances, UPGMA agglomeration
and mean reordering.
Statistical analysis
Prism Software (GraphPad) was used to perform statistical
analysis. Data are presented as mean ± SD. For comparison of
means between two groups, the data were analysed using a
Mann–Whitney U-test. For comparisons involving more than two
data sets, a 2-Way ANOVA was used. A Bonferroni post-test was
applied to correct for multiple comparisons. P values of <0.05 were
considered significant, p values *<0.05, **<0.01, ***<0.001.
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